VeriMombenzophenone-4 est-il sûr pendant la grossesse ?
The SCCS (final opinion adopted 27 Mar 2024) concluded benzophenone‑4 is safe as a cosmetic UV filter up to 5% while noting concerns about potential endocrine‑disrupting properties; there is no harmonised CLP reproductive classification (H361/H360) for BP‑4. CIR’s amended benzophenones review compiles toxicology and biomonitoring data but does not identify BP‑4 as a confirmed reproductive teratogen. These authoritative assessments support hazard = 0, but documented in vitro/alternate endocrine signals reported for benzophenone family members justify a limited mechanistic concern (m=1). Dermal absorption is measurable but relatively low (BP‑4 is water‑soluble with low log Kow ~0.37); SCCS exposure assessment underlies the 5% limit, so exposure = 1 (low but measurable).
Pregnancy-safe products containing benzophenone-4
Related ingredients
Frequently asked questions
- benzophenone-4 est-il sûr pendant la grossesse ?
- The SCCS (final opinion adopted 27 Mar 2024) concluded benzophenone‑4 is safe as a cosmetic UV filter up to 5% while noting concerns about potential endocrine‑disrupting properties; there is no harmonised CLP reproductive classification (H361/H360) for BP‑4. CIR’s amended benzophenones review compiles toxicology and biomonitoring data but does not identify BP‑4 as a confirmed reproductive teratogen. These authoritative assessments support hazard = 0, but documented in vitro/alternate endocrine signals reported for benzophenone family members justify a limited mechanistic concern (m=1). Dermal absorption is measurable but relatively low (BP‑4 is water‑soluble with low log Kow ~0.37); SCCS exposure assessment underlies the 5% limit, so exposure = 1 (low but measurable).
- benzophenone-4 est-il sûr pendant l'allaitement ?
- No authoritative agency (SCCS/CIR/ECHA) lists BP‑4 as a reproductive or lactation hazard; biomonitoring literature for benzophenones documents maternal exposure and detection in biological matrices for some benzophenones (most data are for BP‑3), but direct evidence of adverse effects in breastfeeding infants from BP‑4 is lacking. Mechanistic signals for endocrine activity in the benzophenone class justify a low theoretical mechanism score (m=1). Expected transfer to breast milk appears low/limited for BP‑4 specifically, so exposure = 1 (low but measurable).
- benzophenone-4 est-il sûr pour la peau de bébé ?
- There is no high‑level evidence (harmonised CLP H361/H360 or human developmental toxicity) implicating BP‑4 as a reproductive/teratogenic hazard; therefore hazard = 0. Mechanistic concern remains theoretical (m=1) based on class signals. Because infant skin has higher permeability and the ingredient has measurable dermal absorption in adults, exposure is increased by +1 for infants (adult e=1 → baby e=2).
- Comment VeriMom évalue-t-il benzophenone-4 ?
- VeriMom évalue benzophenone-4 à 87/100 (risque faible) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à benzophenone-4 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à benzophenone-4 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.